Profile data is unavailable for this security.
About the company
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. The Company's bioprocessing business consists of four main franchises: filtration (including fluid management); chromatography; process analytics, and proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. The Company’s chromatography franchise includes a number of products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. The Company’s TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes.
- Revenue in USD (TTM)622.64m
- Net income in USD-17.13m
- Incorporated1981
- Employees1.78k
- LocationRepligen CorpBUILDING 1, SUITE 100, 41 SEYON STREETWALTHAM 02453United StatesUSA
- Phone+1 (781) 449-9560
- Fax+1 (302) 655-5049
- Websitehttps://www.repligen.com/
Mergers & acquisitions
Acquired company | RGEN:NSQ since announced | Transaction value |
---|---|---|
Maravai LifeSciences Holdings Inc | -8.62% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Haemonetics Corporation | 1.36bn | 123.81m | 4.78bn | 3.66k | 38.78 | 5.35 | 20.48 | 3.51 | 2.41 | 2.41 | 26.48 | 17.44 | 0.6001 | 1.87 | 7.02 | 372,224.00 | 5.46 | 5.02 | 6.19 | 6.07 | 54.02 | 51.74 | 9.10 | 8.11 | 2.09 | 27.43 | 0.5823 | 0.00 | 12.01 | 6.23 | 1.87 | 16.40 | -11.04 | -- |
Procept Biorobotics Corp | 199.84m | -100.06m | 5.17bn | 626.00 | -- | 20.57 | -- | 25.85 | -1.95 | -1.95 | 3.89 | 4.64 | 0.5026 | 1.83 | 3.86 | 319,238.00 | -25.16 | -- | -28.58 | -- | 57.39 | -- | -50.07 | -- | 5.07 | -- | 0.1758 | -- | 81.55 | -- | -21.51 | -- | -- | -- |
Inspire Medical Systems Inc | 755.59m | 33.05m | 5.72bn | 1.01k | 175.30 | 8.21 | 150.41 | 7.57 | 1.09 | 1.09 | 25.15 | 23.25 | 1.05 | 2.46 | 9.37 | 747,372.90 | 4.60 | -11.27 | 5.12 | -12.60 | 84.77 | 84.47 | 4.37 | -13.57 | 6.94 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
Lantheus Holdings Inc | 1.50bn | 427.61m | 5.92bn | 834.00 | 14.15 | 5.02 | 12.08 | 3.96 | 6.02 | 6.02 | 21.09 | 16.97 | 0.8383 | 8.28 | 5.09 | 1,794,723.00 | 23.95 | 6.69 | 32.76 | 7.73 | 64.78 | 57.56 | 28.57 | 9.02 | 1.56 | -- | 0.324 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
Merit Medical Systems Inc | 1.33bn | 120.04m | 6.08bn | 6.95k | 51.06 | 4.59 | 27.90 | 4.58 | 2.04 | 2.04 | 22.55 | 22.71 | 0.6334 | 2.29 | 7.41 | 190,772.80 | 5.73 | 2.45 | 6.32 | 2.77 | 46.83 | 44.50 | 9.05 | 3.91 | 3.82 | 31.88 | 0.3619 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
Stevanato Group SpA | 1.16bn | 121.84m | 6.28bn | 5.64k | 45.73 | 4.03 | 30.63 | 5.41 | 0.4537 | 0.4537 | 4.32 | 5.15 | 0.5284 | 2.75 | 2.66 | 206,254.60 | 5.54 | -- | 7.39 | -- | 29.20 | -- | 10.48 | -- | 1.21 | 48.53 | 0.2148 | -- | 10.34 | -- | 1.95 | -- | -- | -- |
Glaukos Corp | 360.35m | -149.57m | 7.92bn | 907.00 | -- | 11.84 | -- | 21.98 | -2.96 | -2.96 | 7.06 | 12.13 | 0.3843 | 1.69 | 7.53 | 397,295.50 | -15.95 | -8.73 | -17.23 | -9.35 | 76.61 | 74.77 | -41.51 | -28.69 | 4.71 | -311.24 | 0.1591 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
Repligen Corp | 622.64m | -17.13m | 8.32bn | 1.78k | -- | -- | 242.55 | 13.37 | -0.3079 | -0.3079 | 11.09 | -- | -- | -- | -- | 349,206.40 | -- | 4.38 | -- | 5.03 | 49.96 | 55.43 | -2.75 | 15.91 | -- | -- | -- | 0.00 | -20.31 | 26.91 | -77.64 | 20.13 | 24.99 | -- |
Henry Schein, Inc. | 12.50bn | 314.00m | 8.41bn | 25.00k | 27.62 | 2.41 | 14.21 | 0.6729 | 2.44 | 2.44 | 96.89 | 27.99 | 1.22 | 4.77 | 7.73 | 499,960.00 | 2.97 | 6.09 | 4.86 | 10.44 | 31.59 | 30.04 | 2.42 | 4.40 | 0.817 | 6.23 | 0.348 | 0.00 | -2.44 | 5.55 | -22.68 | -0.1456 | 21.27 | -- |
Bruker Corp | 3.24bn | 304.90m | 8.48bn | 9.71k | 27.01 | 4.70 | 17.96 | 2.62 | 2.07 | 2.07 | 21.89 | 11.92 | 0.6527 | 1.51 | 5.73 | 333,913.70 | 6.12 | 8.38 | 8.14 | 11.40 | 49.31 | 49.85 | 9.38 | 11.39 | 0.7085 | 26.83 | 0.5549 | 9.81 | 17.14 | 9.36 | 44.03 | 18.91 | 16.79 | 4.56 |
Masimo Corp | 2.04bn | 78.60m | 8.61bn | 3.80k | 110.63 | 5.88 | 49.69 | 4.22 | 1.45 | 1.45 | 37.72 | 27.35 | 0.6715 | 1.77 | 5.52 | 537,526.30 | 2.58 | 8.65 | 3.23 | 10.31 | 50.05 | 57.30 | 3.85 | 12.03 | 1.11 | 2.84 | 0.3456 | 0.00 | 0.6042 | 19.00 | -43.21 | -15.96 | 31.06 | -- |
Penumbra Inc | 1.16bn | 34.55m | 9.07bn | 4.20k | 274.60 | 8.21 | 148.87 | 7.79 | 0.8602 | 0.8602 | 29.71 | 28.78 | 0.7897 | 1.04 | 6.08 | 277,089.50 | 2.34 | 2.32 | 2.61 | 2.61 | 65.70 | 63.90 | 2.97 | 3.17 | 3.25 | -- | 0.0218 | 0.00 | 24.95 | 18.93 | 4,643.16 | 68.60 | 9.64 | -- |
Teleflex Inc | 3.03bn | 238.01m | 9.08bn | 14.50k | 38.78 | 2.03 | 17.99 | 3.00 | 5.04 | 5.03 | 64.01 | 96.50 | 0.404 | 2.11 | 6.76 | 208,677.50 | 3.18 | 5.86 | 3.46 | 6.42 | 55.99 | 54.43 | 7.87 | 14.62 | 1.39 | 6.61 | 0.2818 | 15.84 | 6.57 | 3.97 | -1.47 | 12.73 | 2.51 | 0.00 |
Bio Rad Laboratories Inc | 2.58bn | -778.69m | 10.06bn | 8.03k | -- | 1.36 | -- | 3.90 | -27.32 | -27.32 | 90.77 | 267.46 | 0.2294 | 1.49 | 5.61 | 321,321.20 | -6.92 | 9.08 | -7.26 | 9.60 | 54.43 | 55.55 | -30.18 | 41.97 | 4.52 | 0.2612 | 0.1383 | 0.00 | -4.67 | 3.13 | 82.43 | -- | 3.83 | -- |
Holder | Shares | % Held |
---|---|---|
T. Rowe Price Associates, Inc. (IM)as of 31 Aug 2024 | 6.12m | 10.93% |
The Vanguard Group, Inc.as of 30 Jun 2024 | 4.99m | 8.91% |
BlackRock Fund Advisorsas of 30 Jun 2024 | 4.97m | 8.87% |
SSgA Funds Management, Inc.as of 30 Jun 2024 | 1.74m | 3.10% |
BlackRock Advisors LLCas of 30 Jun 2024 | 1.50m | 2.67% |
Sands Capital Management LLCas of 30 Jun 2024 | 1.42m | 2.54% |
Brown Capital Management LLCas of 30 Jun 2024 | 1.29m | 2.31% |
Macquarie Investment Management Business Trustas of 30 Jun 2024 | 1.22m | 2.18% |
Fidelity Management & Research Co. LLCas of 30 Jun 2024 | 1.19m | 2.13% |
Invesco Advisers, Inc.as of 30 Jun 2024 | 1.13m | 2.01% |